newsfilter
← Latest News
ACCESS Newswire·

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure.FREMONT, CA / ACCESS Newswire / February